China completes largest ever dry eye disease clinical trial

Zhaoke Ophthalmology has announced that the Phase III clinical trial of one of the company's core drug candidates, Cyclo...

August 19, 2021 | Thursday | News
APAC sponsors/CROs inclination to innovative and optimized DCT model trial designs

Clinical trials in a drug development process often face multiple hurdles around patient recruitment and management resu...

August 5, 2021 | Thursday | Opinion
Longer-interval of Pfizer vaccine dose boosts antibody levels: Study

Universities of Sheffield, Oxford, Liverpool, Newcastle, and Birmingham, with support from the UK Coronavirus Immunology...

July 23, 2021 | Friday | News
Nichi Glucan progresses to clinical studies in autism spectrum disorder

Beneficial effects in autism spectrum disorders of the Japanese food supplement Nichi-Glucan (www.nichiglucan.com), a bi...

June 28, 2021 | Monday | Opinion
eTheRNA, VUB expand collaboration to engineer next-generation mRNA therapeutics

eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...

June 23, 2021 | Wednesday | News
Medidata extends a secure platform for Decentralization of Clinical Trials (DCT)

Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (D...

June 16, 2021 | Wednesday | News
Korea's IVI to develop adaptive Ph 1b/2a schistosomiasis vaccine trial

The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...

June 3, 2021 | Thursday | News
Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment

Tiziana Life Sciences plc, a UK based biotechnology company focused on innovative therapeutics for oncology, inflammatio...

May 5, 2021 | Wednesday | News
China explores new mode of pharmaceutical R&D

Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (Georg...

May 3, 2021 | Monday | News
Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan

FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...

April 21, 2021 | Wednesday | News
TrialWire launches StudyBoost, the Clinical trial insurance plan

TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...

March 23, 2021 | Tuesday | News
UK conducts innovative COVID-19 trials with deliberate volunteered infection

United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...

March 2, 2021 | Tuesday | News
Panthera to evaluate AstraZeneca’s AZD7442 for the potential prevention of COVID-19

Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...

December 30, 2020 | Wednesday | News
Tychan to begin Ph 3 trial for mAb TY027 against COVID-19

In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...

December 14, 2020 | Monday | News
Contract for innovative delivery system for COVID-19 vaccine

Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...

November 16, 2020 | Monday | News
CEPI funds Sichuan Clover for COVID-19 vaccine development

CEPI, the Coalition for Epidemic Preparedness Innovations, based in Norway, has announced that it will fund the developm...

November 5, 2020 | Thursday | News
Russia- Destination of choice for Asian pharma companies

Asian biotech industry has been experiencing an escalating boom over the past several years. Pharmaceutical companies ha...

November 3, 2020 | Tuesday | Opinion
Daewoong pharma partners with Tufts medical center for Ph 2 trial with Niclosamide

Daewoong Pharmaceutical announced on 26 Oct 2020 that the collaborative clinical research agreement betwe...

October 30, 2020 | Friday | News